Sarepta Therapeutics Revenue Charts (NASDAQ:SRPT)
$42.44 $0.1 (0.24%) SRPT stock closing price Jul 26, 2017 (Closing)
The latest 2017-Q2 Sarepta Therapeutics revenue is 35.01M. Compare Sarepta Therapeutics revenue chart with Kythera Biopharma revenue, DBV Tech revenue.
Sarepta Therapeutics Revenue Chart
You can do annual as well as quarterly comparisons of Sarepta Therapeutics Inc net sales with its competitor companies like Kythera Biopharma, DBV Tech. Over the 5 year period Sarepta Therapeutics revenue in 2012 was highest at 37.32M. In the latest quarter, SRPT revenue 2017-Q2 has changed from 16.34M to 35.01M implying an increase of 114.26%.
Sarepta Therapeutics Quarterly Revenue
* Past 5 years Range
|Max SRPT Revenue||$35.01M||Jun, 2017|
|Min SRPT Revenue||$0.03M||Dec, 2014|
Sarepta Therapeutics Annual Revenue
* Past 5 years Range
|Max SRPT Revenue||$37.32M||Dec, 2012|
|Min SRPT Revenue||$1.25M||Dec, 2015|
Sarepta Therapeutics Annual Revenue VS Peers
|Sarepta Therapeutics Revenue||$5.42M||$1.25M||$9.75M||$14.21M||$37.32M|
|Kythera Biopharma Revenue||----||----||----||----||$19.68M|
|DBV Tech Revenue||$10.05M||$6.84M||$6.32M||$5.08M||$3.57M|
|Aviragen Therapeutics Revenue||$9.3M||$24.6M||$68.7M||$33.6M||$0.63M|
|BioCryst Pharma Revenue||$26.35M||$48.25M||$13.6M||$17.33M||$26.29M|
|Gilead Sciences Revenue||$30.39B||$32.64B||$24.89B||$11.2B||$9.7B|
Sarepta Therapeutics Stock Articles
Sarepta Therapeutics News
Revenue or net sales is the total amount of money that a company brings in through its various business activities before any costs or expenses are deducted. Revenue is also known as the topline or net sales or gross income. Revenue is for a specific period of time and appears as the "top line" in an income statement. By subtracting the costs or expenses from Sarepta Therapeutics topline, we arrive at the bottom line for the company. Growing revenues over a period of time generally indicate that the company is in good health, however other factors need to be factored. Revenue can be calculated in two ways based on the type of accounting followed: accrual accounting or cashflow accounting. It is useful to compare Sarepta Therapeutics revenue with peers Cambrex topline, Halozyme Therapeutics topline, Aviragen Therapeutics topline; to see how the company is doing with respect to its peers.